85-1780-73　BML-210, HDAC Inhibitor (N1-(2-aminophenyl)-N8-phenyloctanediamide) 25mg　CAS No:537034-17-6　136760

特徴

• A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10uM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.
• Solubility:DMSO (~25mg/ml) or Ethanol (~10mg/ml, warm)
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：25mg
• Source Antigen：Synthetic
• Grade：Highly Purified
• Purity：~98% (TLC)
• Form：Supplied as a lyophilized powder in PBS. Reconstitute with sterile dH20.
• Molecular Formula：C20H25N3O2
• Molecular Weight Non Ab：339.4
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：537034-17-6

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]